Revelation Biosciences annual r&d spending
2021
2022
2023
2024
2025
Revelation Biosciences R&D Spending Growth & History (REVB)
Revelation Biosciences's r&d spending was $4.1M for fiscal 2025.
View full Revelation Biosciences company overviewRevelation Biosciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.1M | $514,861 | +14.51% |
| 2024 | 2024-12-31 | $3.5M | −$596,906 | −14.40% |
| 2023 | 2023-12-31 | $4.1M | −$1.2M | −22.90% |
| 2022 | 2022-12-31 | $5.4M | −$1.5M | −22.23% |
| 2021 | 2021-12-31 | $6.9M | — | — |
Revelation Biosciences quarterly r&d spending
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.9M | $600,444 | +45.56% |
| Q1 2026 | 2026-03-31 | $1.4M | $518,031 | +60.32% |
| Q4 2025 | 2025-12-31 | $964,190 | $358,686 | +59.24% |
| Q3 2025 | 2025-09-30 | $922,857 | $91,876 | +11.06% |
| Q2 2025 | 2025-06-30 | $1.3M | −$76,949 | −5.52% |
| Q1 2025 | 2025-03-31 | $858,830 | $141,248 | +19.68% |
| Q4 2024 | 2024-12-31 | $605,504 | −$454,480 | −42.88% |
| Q3 2024 | 2024-09-30 | $830,981 | −$820,386 | −49.68% |
| Q2 2024 | 2024-06-30 | $1.4M | $485,651 | +53.41% |
| Q1 2024 | 2024-03-31 | $717,582 | $192,309 | +36.61% |
| Q4 2023 | 2023-12-31 | $1.1M | $720,013 | +211.79% |
| Q3 2023 | 2023-09-30 | $1.7M | $1.3M | +332.79% |
| Q2 2023 | 2023-06-30 | $909,278 | −$66,305 | −6.80% |
| Q1 2023 | 2023-03-31 | $525,273 | −$3.2M | −85.73% |
| Q4 2022 | 2022-12-31 | $339,971 | −$2.3M | −87.25% |
| Q3 2022 | 2022-09-30 | $381,566 | −$1.2M | −75.11% |
| Q2 2022 | 2022-06-30 | $975,583 | −$183,922 | −15.86% |
| Q1 2022 | 2022-03-31 | $3.7M | $2.1M | +136.36% |
| Q4 2021 | 2021-12-31 | $2.7M | — | — |
| Q3 2021 | 2021-09-30 | $1.5M | — | — |
| Q2 2021 | 2021-06-30 | $1.2M | — | — |
| Q1 2021 | 2021-03-31 | $1.6M | — | — |
Revelation Biosciences r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Revelation Biosciences's r&d spending decreased from $6.9M to $4.1M, a change of −$2.9M. The latest reported quarter, Q2 2026, shows $1.9M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Revelation Biosciences source filings ↗